| T1DM | Type 1 diabetes mellitus |
| T2DM | Type 2 diabetes mellitus |
| hPSC | human pluripotent stem cells |
| IDF | International Diabetes Federation |
| ADA | American Diabetes Association |
| GDM | gestational diabetes mellitus |
| MODY | maturity-onset diabetes of the young |
| hESC | human embryonic stem cells |
| ER | Endoplasmic reticulum |
| hiPSC | human induced pluripotent stem cells |
| TCR | T cell receptor |
| MHC | Major histocompatibility complexes |
| APC | Antigen presenting cells |
| GSIS | glucose-stimulated insulin secretion |
| NOD-scid | non-obese diabeteic/severe combined immunodeficiency |
| HLA | human leukocyte antigens |
| PD-L1 | Programmed death-ligand 1 |
| PD-1 | Programmed death 1 |
| DSB | Double-stranded DNA break |
| ZFN | Zinc finger nucleases |
| TALEN | Transcription activator-like effector nuclease |
| CRISPR | Clustered Regularly interspaced-Short Palindromic Repeats |
| TALEs | Transcription activator-like effectors |
| sgRNA | short noncoding guide RNAs |
| Cas9 | CRISPR-associated protein 9 |
| B2M | Beta 2 microglobulin |
| KO | knockout |
| MSC | mesenchymal stem cells |
| MMTT | mixed meal tolerance test |
| IBMIR | Instant blood-mediated inflammatory reaction |